## Abstract Myocardial perfusion reserve (MPR, defined as the ratio of the maximum myocardial blood flow (MBF) to the baseline) is an indicator of coronary artery disease and myocardial microvascular abnormalities. First‐pass contrast‐enhanced magnetic resonance imaging (CE‐MRI) using gadolinium (G
Quantification of MRI measured myocardial perfusion reserve in healthy humans: A comparison with positron emission tomography
✍ Scribed by Thomas Fritz-Hansen; Jens D. Hove; Klaus F. Kofoed; Henning Kelbaek; Henrik B.W. Larsson
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 254 KB
- Volume
- 27
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Purpose
To validate a noninvasive quantitative MRI technique, the K~i~ perfusion method, for myocardial perfusion in humans using ^13^N‐ammonia PET as a reference method.
Materials and Methods
Ten healthy males (64 ± 8 years) were examined with combined PET and MRI perfusion imaging at rest and during stress induced by dipyridamole in order to determine the myocardial perfusion reserve. Myocardial and blood time concentration curves obtained by Gd‐DTPA‐enhanced MRI and ^13^N‐ammonia PET were fitted by a two‐compartment perfusion model.
Results
Mean perfusion values (±SD) derived from the MRI method at rest and at hyperemia were 80 ± 20 and 183 ± 56 mL/min/100 g, respectively. The same data for PET were 71 ± 16 and 203 ± 67 mL/min/100 g. A linear relationship was observed between MRI and PET‐derived myocardial perfusion reserve for regional and global data. Linear regression for the global absolute perfusion reserve gave a correlation coefficient of 0.96 (P < 0.004, y=0.83x‐6.9). A good agreement between the two methods to determine low or high perfusion reserves was found.
Conclusion
Our data provide validation of the perfusion marker K~i~ derived by the MRI method as a quantitative marker for myocardial perfusion in healthy humans. J. Magn. Reson. Imaging 2008;27:818–824. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
The role of serotonin in CNS function and in many neuropsychiatric diseases (e.g., schizophrenia, affective disorders, degenerative dementias) support the development of a reliable measure of serotonin receptor binding in vivo in human subjects. To this end, the regional distribution and intrasubjec